Jesse C. Patterson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jesse C. Patterson has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Michael B. Yaffe
Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
37 shared publications - Andreas Varkaris
Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts
33 shared publications - David Johnson Einstein
Beth Israel Deaconess Medical Center, Boston, Massachusetts
33 shared publications - Fang Xie
Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States of America
33 shared publications - John T. Isaacs
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins University School of Medicine, Baltimore, USA
33 shared publications - Jun Luo
15James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland
33 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in enzalutamide treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in enzalutamide treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Identification of paired centromeres from sister chromatids
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Identification of paired centromeres from sister chromatids
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Seven Supplementary Figures and Legends
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Seven Supplementary Figures and Legends
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in abiraterone treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in abiraterone treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in vehicle treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Chromatin structure in vehicle treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Video montage comparing mitosis of vehicle control with abiraterone treated C4-2 cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Video montage comparing mitosis of vehicle control with abiraterone treated C4-2 cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Cellular division that occurred in a manner that was not parallel to the growth surface
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Cellular division that occurred in a manner that was not parallel to the growth surface
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Example of mitotic arrest and cell death caused by abiraterone and onvansertib
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Example of mitotic arrest and cell death caused by abiraterone and onvansertib